Literature DB >> 22517264

HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum.

Shaji Theodore1, Wayne A Cass, Linda P Dwoskin, William F Maragos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22517264      PMCID： PMC4548822          DOI： 10.1002/syn.21564

Source DB:  PubMed          Journal:  Synapse        ISSN： 0887-4476            Impact factor:   2.562


× No keyword cloud information.
  10 in total

1.  Variable progression of HIV-associated dementia.

Authors:  F H Bouwman; R L Skolasky; D Hes; O A Selnes; J D Glass; T E Nance-Sproson; W Royal; G J Dal Pan; J C McArthur
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

Review 2.  Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia.

Authors:  A Nath; C Anderson; M Jones; W Maragos; R Booze; C Mactutus; J Bell; K F Hauser; M Mattson
Journal:  J Psychopharmacol       Date:  2000       Impact factor: 4.153

3.  Methamphetamine rapidly decreases vesicular dopamine uptake.

Authors:  J M Brown; G R Hanson; A E Fleckenstein
Journal:  J Neurochem       Date:  2000-05       Impact factor: 5.372

4.  The AIDS dementia complex: I. Clinical features.

Authors:  B A Navia; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

5.  Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.

Authors:  S Theodore; W A Cass; W F Maragos
Journal:  Neuroscience       Date:  2005-12-07       Impact factor: 3.590

6.  Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.

Authors:  L Teng; P A Crooks; P K Sonsalla; L P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  1997-03       Impact factor: 4.030

7.  HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.

Authors:  Wayne A Cass; Michael E Harned; Laura E Peters; Avindra Nath; William F Maragos
Journal:  Brain Res       Date:  2003-09-12       Impact factor: 3.252

8.  HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.

Authors:  Jun Zhu; Charles F Mactutus; David R Wallace; Rosemarie M Booze
Journal:  J Pharmacol Exp Ther       Date:  2009-03-26       Impact factor: 4.030

9.  Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum.

Authors:  Shaji Theodore; Wayne A Cass; William F Maragos
Journal:  Exp Neurol       Date:  2006-02-28       Impact factor: 5.330

Review 10.  Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.

Authors:  Shaji Theodore; Wayne A Cass; Avindra Nath; William F Maragos
Journal:  Curr HIV Res       Date:  2007-05       Impact factor: 1.581
  10 in total
  16 in total

1.  HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function.

Authors:  James P Kesby; Julia A Najera; Benedetto Romoli; Yiding Fang; Liana Basova; Amanda Birmingham; Maria Cecilia G Marcondes; Davide Dulcis; Svetlana Semenova
Journal:  Brain Behav Immun       Date:  2017-05-08       Impact factor: 7.217

2.  Age-Related Decrease in Tyrosine Hydroxylase Immunoreactivity in the Substantia Nigra and Region-Specific Changes in Microglia Morphology in HIV-1 Tg Rats.

Authors:  David R Goulding; Andrew Kraft; Peter R Mouton; Christopher A McPherson; Valeria Avdoshina; Italo Mocchetti; G Jean Harry
Journal:  Neurotox Res       Date:  2019-07-08       Impact factor: 3.911

3.  Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.

Authors:  Christina J Schier; William D Marks; Jason J Paris; Aaron J Barbour; Virginia D McLane; William F Maragos; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurosci       Date:  2017-05-04       Impact factor: 6.167

Review 4.  Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.

Authors:  Wesley N Wayman; Lihua Chen; Amanda L Persons; T Celeste Napier
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

Review 5.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

6.  Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory.

Authors:  Gladys Chompre; Emmanuel Cruz; Lucianette Maldonado; Vanessa Rivera-Amill; James T Porter; Richard J Noel
Journal:  Neurobiol Dis       Date:  2012-08-25       Impact factor: 5.996

7.  Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures.

Authors:  Angela H Shin; Stanley A Thayer
Journal:  Mol Cell Neurosci       Date:  2012-12-23       Impact factor: 4.314

8.  The effects of HIV-1 regulatory TAT protein expression on brain reward function, response to psychostimulants and delay-dependent memory in mice.

Authors:  James P Kesby; Athina Markou; Svetlana Semenova
Journal:  Neuropharmacology       Date:  2016-06-15       Impact factor: 5.250

9.  Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target?

Authors:  Avindra Nath; Joseph Steiner
Journal:  Exp Neurol       Date:  2013-11-15       Impact factor: 5.330

10.  Effects of HIV/TAT protein expression and chronic selegiline treatment on spatial memory, reversal learning and neurotransmitter levels in mice.

Authors:  James P Kesby; Athina Markou; Svetlana Semenova
Journal:  Behav Brain Res       Date:  2016-05-17       Impact factor: 3.332
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.